Recently, cGAS-STING pathway has become a hot spot in cancer immunotherapy, since STING agonists can synergize with other cancer immunotherapies, including cancer vaccines, immune checkpoint inhibitors and adoptive T cell transfer, to boost the anticancer immunity in advanced cancer treatment41,42. Here, STING1 is linked to cancer.